Cargando…
Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity
Pancreatic cancer has remained one of the most devastating and lethal malignancies characterized by local invasion, distant metastasis and a high degree of chemoresistance. Insulin-like growth factor binding protein 2 (IGFBP-2) is a member of the IGFBP family of proteins, and it is highly expressed...
Autores principales: | Liu, Huan, Li, Le, Chen, Hua, Kong, Rui, Pan, Shangha, Hu, Jisheng, Wang, Yongwei, Li, Yilong, Sun, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617455/ https://www.ncbi.nlm.nih.gov/pubmed/28977895 http://dx.doi.org/10.18632/oncotarget.18669 |
Ejemplares similares
-
Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer
por: Li, Yilong, et al.
Publicado: (2019) -
Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network
por: Li, Yilong, et al.
Publicado: (2016) -
Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer
por: Cheng, Chundong, et al.
Publicado: (2022) -
UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1
por: Chen, Hongze, et al.
Publicado: (2019) -
Lnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis
por: Zhang, Tao, et al.
Publicado: (2021)